ES401603A1 - X-ray contrast agents - Google Patents

X-ray contrast agents

Info

Publication number
ES401603A1
ES401603A1 ES401603A ES401603A ES401603A1 ES 401603 A1 ES401603 A1 ES 401603A1 ES 401603 A ES401603 A ES 401603A ES 401603 A ES401603 A ES 401603A ES 401603 A1 ES401603 A1 ES 401603A1
Authority
ES
Spain
Prior art keywords
contrast agents
ray contrast
hydroxyacetamido
acetamido
physiologically compatible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES401603A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES401603A1 publication Critical patent/ES401603A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Procedure for the preparation of X-ray contrast agents containing 3-acetamido-5-hydroxyacetamido-2,4,6-triiodobenzoic acid in the form of their water soluble salts with physiologically compatible bases, characterized in that per 100 ml of water 19.8 to 74.4 g of 3-acetamido-5-hydroxyacetamido-2,4,6-triiodobenzoic acid and the equivalent amount of one or more physiologically compatible bases are dissolved, the solution is filled in ampoules or multivials and sterilized . (Machine-translation by Google Translate, not legally binding)
ES401603A 1971-04-10 1972-04-08 X-ray contrast agents Expired ES401603A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2118219A DE2118219C3 (en) 1971-04-10 1971-04-10 New X-ray contrast medium

Publications (1)

Publication Number Publication Date
ES401603A1 true ES401603A1 (en) 1975-02-16

Family

ID=5804754

Family Applications (1)

Application Number Title Priority Date Filing Date
ES401603A Expired ES401603A1 (en) 1971-04-10 1972-04-08 X-ray contrast agents

Country Status (15)

Country Link
AT (2) AT316523B (en)
AU (1) AU463194B2 (en)
BE (1) BE781889A (en)
CA (1) CA987339A (en)
CH (1) CH574740A5 (en)
DD (1) DD95265A5 (en)
DE (1) DE2118219C3 (en)
ES (1) ES401603A1 (en)
FR (1) FR2132810B1 (en)
GB (1) GB1391843A (en)
HU (1) HU163446B (en)
IL (1) IL39167A (en)
IT (1) IT1048929B (en)
NL (1) NL7204789A (en)
ZA (1) ZA722396B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH641682A5 (en) * 1978-10-05 1984-03-15 Daeniker Felix X-ray contrast medium

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076024A (en) * 1954-02-19 1963-01-29 Sterling Drug Inc Acylated 3, 5-diaminopolyhalobenzoic acids
DE1129260B (en) * 1961-05-12 1962-05-10 Schering Ag X-ray contrast media

Also Published As

Publication number Publication date
ZA722396B (en) 1972-12-27
IL39167A0 (en) 1972-06-28
NL7204789A (en) 1972-10-12
HU163446B (en) 1973-08-28
DE2118219A1 (en) 1972-10-26
CA987339A (en) 1976-04-13
DD95265A5 (en) 1973-01-20
FR2132810A1 (en) 1972-11-24
AU463194B2 (en) 1975-07-02
DE2118219B2 (en) 1980-07-03
FR2132810B1 (en) 1975-03-14
AU4063372A (en) 1973-10-04
IL39167A (en) 1976-01-30
BE781889A (en) 1972-10-10
IT1048929B (en) 1980-12-20
GB1391843A (en) 1975-04-23
CH574740A5 (en) 1976-04-30
AT318801B (en) 1974-11-25
AT316523B (en) 1974-07-10
DE2118219C3 (en) 1981-07-16

Similar Documents

Publication Publication Date Title
SE7903817L (en) MORANOLIN DERIVATIVES
LV5801A4 (en) Omeprazole added to the basal islet
IL40448A (en) Bis-imidazolium(or benzimidazolium)salts,their preparation and pharmaceutical compositions containing them
FR2285857A1 (en) MEDICAL CONTROL AGENT INTENDED TO BE ADMINISTERED BY INTRAVASCULAR ROUTE
CH541534A (en) Preparation of glyoxylic acid
ES460743A1 (en) Preserving liquid antacid medicinal formulations
ES370058A1 (en) PROCEDURE FOR THE PREPARATION OF EFFERVESCENT PHARMACEUTICAL COMPOSITIONS.
ES399609A1 (en) Preparation of an acidified milk product in powder form
ES478272A1 (en) A PROCEDURE FOR THE PREPARATION OF A STABLE AND STERILE AQUEOUS CISPLATIN SOLUTION.
ES455691A1 (en) N-Benzhydryl-3-methyl-3-(dialkoxy)benzyl-piperazines
ES401603A1 (en) X-ray contrast agents
BE786497A (en) SUPERIOR APPROVED FOR RETINOIC ACID, ITS SALTS AND THEIR PREPARATION
ES409333A1 (en) Stabilization of aqueous solutions of bromine
EG10508A (en) Method for preparation of 5-aryl 2,3-dihydro-2,2(or 3,3)dimethyl-5h-imidazo(2,1-a)isoindol-5-ols and 2(4,4(5,5)dimethyl-2-imidazolin-2-yl)bensophenone acid addition salts used as autidepressant drug
ES387532A1 (en) Procedure to manufacture a medicine. (Machine-translation by Google Translate, not legally binding)
BE792803A (en) OPTICALLY ACTIVE 8,12-DIISOPROSTANOIC ACID DERIVATIVES, THEIR PREPARATION AND COMPOSITIONS CONTAINING
ES294928A1 (en) A procedure to prepare a liquid and stable composition of tetracycline (Machine-translation by Google Translate, not legally binding)
IL34468A0 (en) Acid addition salts of indenopyridine derivatives,their preparation and pharmaceutical compositions containing them
IL40623A (en) 14,15-dihydro-eburnamine-14-carboxylic acid derivatives and salts thereof,their preparation and pharmaceutical compositions containing them
ES393894A1 (en) Piperidinemethyl ethers
GB1472816A (en) Circulatory pharmaceutical compositions containing tetrahydroal stonine
FR2042290A1 (en) Compositions containing uridine 5 diphospho- - glucose for treatment of liver disorders
Fitzwilliams The treatment of carcinoma by lead colloids
GB1045969A (en) Sodium betaine aspartate
IL36985A (en) Pharmaceutical compositions containing acid addition salts of benzyl-(or beta-phenylethyl)-dimethylguanidine,certain such novel salts and their preparation